By Ben Hirschler MADRID (Reuters) – Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline had similarly good results in separate clinical trials, leaving doctors with little to choose between the two skin cancer courses. The latest…
Source:Roche, GSK melanoma pill combinations look similar in showdown
Monday, September 29, 2014
Roche, GSK melanoma pill combinations look similar in showdown
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment